California Fertility Partners, A Medical Group, Professional Corporations
Form 483 issued December 3, 2024
- Inspection
- Nov 20 – Dec 3, 2024
- Observations
- 1
- Pages
- 3
- FEI number
- 3003942615
In short: On December 3, 2024, FDA issued a Form 483 with 1 observation to California Fertility Partners, A Medical Group, Professional Corporations (FEI 3003942615) after an inspection that ran Nov 20 – Dec 3, 2024. Most observations concern hCT/P; the most-cited regulation is 21 CFR 1271.75 (how do I screen a donor?).
At a glance
1 of 1 observations on this 483 concern hct/p.
Most cited: 21 CFR 1271.75(a)(1) (1×)
What FDA observed
Preview: the opening words of each observation- 01
Donors were not screened by a review of relevant medical records for risk factors and clinical…
This inspection in context
Questions about this 483
What did FDA find at California Fertility Partners, A Medical Group, Professional Corporations?
FDA listed 1 observation on this Form 483, mostly about hCT/P. The most-cited regulation is 21 CFR 1271.75 (how do I screen a donor?). The opening words of each observation are shown on this page.
When was California Fertility Partners, A Medical Group, Professional Corporations inspected by FDA?
The inspection ran Nov 20 – Dec 3, 2024, and the Form 483 is dated December 3, 2024.
How do I get the full Form 483 for California Fertility Partners, A Medical Group, Professional Corporations?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.